A.R.T. Advisors, LLC - SYROS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$204,000
+71.4%
29,462
+129.7%
0.01%
+42.9%
Q2 2019$119,000
+6.2%
12,827
+16.6%
0.01%
+40.0%
Q2 2018$112,00011,0030.01%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,439,895$18,747,0004.66%
Bain Capital Life Sciences Investors, LLC 5,785,036$31,528,0002.07%
Omega Fund Management, LLC 2,274,831$12,398,0001.40%
Altium Capital Management LP 1,076,942$5,869,0001.36%
Samsara BioCapital, LLC 2,189,199$10,599,0001.31%
Sio Capital Management, LLC 800,000$4,360,0001.08%
Flagship Pioneering Inc. 2,938,494$16,015,0000.20%
EcoR1 Capital, LLC 1,000,000$5,450,0000.20%
Artal Group S.A. 1,700,000$9,265,0000.19%
ACT CAPITAL MANAGEMENT, LLC 52,500$287,0000.15%
View complete list of SYROS PHARMACEUTICALS INC shareholders